Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.
about
Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infectionReversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cellsTrauma equals danger--damage control by the immune systemThe influence of innate and adaptive immune responses on atherosclerosisMechanisms linking traffic-related air pollution and atherosclerosisThe Roles of CD137 Signaling in AtherosclerosisInflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm researchEndothelial CD47 promotes vascular endothelial-cadherin tyrosine phosphorylation and participates in T cell recruitment at sites of inflammation in vivoT cell costimulatory and coinhibitory pathways in vascular inflammatory diseasesLoss of ABCG1 influences regulatory T cell differentiation and atherosclerosis.CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response.PI3K p110γ deletion attenuates murine atherosclerosis by reducing macrophage proliferation but not polarization or apoptosis in lesions.Innate and adaptive immunity in atherosclerosis.Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation.Yin-Yang of costimulation: crucial controls of immune tolerance and function.Attenuation of immune-mediated influenza pneumonia by targeting the inducible co-stimulator (ICOS) molecule on T cellsT cells in vascular inflammatory diseasesMobilization of regulatory T cells in response to carotid injury does not influence subsequent neointima formation.Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.Lymphocytes in atherosclerosis.Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia.Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.Inducible costimulator controls migration of T cells to the lungs via down-regulation of CCR7 and CD62LCCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in miceImmune modulation of atherosclerosisMurine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression.Plasmacytoid dendritic cells in atherosclerosis.Silencing of lipid metabolism genes through IRE1α-mediated mRNA decay lowers plasma lipids in mice.Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese IndividualsThe Costimulatory Molecule ICOS Regulates Host Th1 and Follicular Th Cell Differentiation in Response to Plasmodium chabaudi chabaudi AS Infection.Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance.Adaptive immunity in atherogenesis: new insights and therapeutic approaches.Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosisEngineering nanomaterials to address cell-mediated inflammation in atherosclerosis.Peripheral Th17/Treg imbalance in patients with atherosclerotic cerebral infarction.B7h (ICOS-L) maintains tolerance at the fetomaternal interfaceFAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice
P2860
Q21131435-56FC48B8-C500-46E0-A69A-2FB80AC416F3Q21245299-8FB5D0E9-F6CF-4608-AA89-368E3E823128Q26860731-98E28FBE-BD0F-40EA-B29B-FAB2C2325991Q27000370-4702632E-F9FC-4462-B827-9EDB51327AA5Q27014688-10659BD1-D0B9-432C-9502-2EA46CC2B9F2Q28076613-372E5EE2-826E-4B90-814C-CF2451C04E2BQ28084855-D8FA5917-E133-40C9-AE6F-4A4CFCAE86B3Q28271467-28229FF2-CDDB-4363-9C41-1E2F1ABFD2FBQ28396774-F5381F1F-B73F-4D69-BCE4-9FAF3841AE2FQ30355065-DEA11DBE-786A-4F26-BBA1-368543D7FB38Q30426856-07CA409D-28D4-4EFE-92C7-F8D7AE2C527FQ31133175-3459FDDA-443D-4ACF-9A51-76B8AD591FE5Q33659705-17672B4A-5593-4B44-8BEE-1CFADED4DC07Q33834302-1EBF8983-D13A-4EB3-B3AC-63A8F292BBE8Q33872168-E5A430B8-9B9A-437D-BBA4-23D299126174Q33910157-4A9E6C50-5C30-45C2-B983-9762781AAF84Q34336323-B27BF081-45AD-468E-9CCA-E14C8056D88BQ34512477-158FAFE1-AB71-4E41-B19C-4E8AE4614847Q34582934-A9D48845-E99F-431F-8052-EED4E05A1474Q34847859-35BFE6C0-6CDD-49C5-AFDF-CD6A64B57575Q35013382-17B2FF62-B464-4491-AD63-3543205B44AFQ35082438-C10643ED-C30E-44F7-AB01-BC30116F06B0Q35133174-D8FF4780-9CD4-4CC5-B93D-0302CE109C31Q35174901-8B0A0D29-6F92-4C02-A956-31FE8BD63721Q35527988-7DADDFE2-D04E-4A25-9982-C5E953A306A5Q35572404-6C2A10B3-6A28-4BE4-B04A-0D68463FB7D3Q35599691-844F48A2-2B94-4655-900E-FDDFE51CFB34Q35740112-7D01FC98-193D-4CBD-944F-4654D742FFE2Q36064574-2F5B5B4E-F3AF-417C-A520-5CBA832357E5Q36330343-2A495E44-865A-4BC8-8C66-7495FC521F96Q36339546-11BAD4FD-87AA-477C-B368-02D5B7FE1631Q36443069-AD69F2CC-B902-4360-A42E-C084F1EA8764Q36455565-9112EFC8-BDB2-4D13-8215-AD29C711F1F1Q36497196-6AFA25D5-D190-42C4-BEE4-56B0FEE66832Q36497238-13BB12A9-56D8-45EA-992E-1F2A328455AEQ36638113-EDCE5BBE-B597-4483-826B-DA7AC9440BF6Q36848196-51B96D83-1260-488F-ADAE-6FB00C8C8701Q36853390-1693FD04-94B2-407B-8F01-369FE5334FBCQ36888297-CEBE87EF-1AD2-4CB1-BDE3-13838E455B73Q36974226-16E55E06-E3B2-44A0-B68C-6E875A59C385
P2860
Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Impaired regulatory T-cell res ...... ucible costimulatory molecule.
@en
Impaired regulatory T-cell res ...... ucible costimulatory molecule.
@nl
type
label
Impaired regulatory T-cell res ...... ucible costimulatory molecule.
@en
Impaired regulatory T-cell res ...... ucible costimulatory molecule.
@nl
prefLabel
Impaired regulatory T-cell res ...... ucible costimulatory molecule.
@en
Impaired regulatory T-cell res ...... ucible costimulatory molecule.
@nl
P2093
P1433
P1476
Impaired regulatory T-cell res ...... ucible costimulatory molecule.
@en
P2093
Andrew H Lichtman
Arlene H Sharpe
Galina Sukhova
James Lederer
Malcolm MacConmara
Nir Grabie
Rajat Gupta
Rosa Dacosta
P304
P356
10.1161/CIRCULATIONAHA.106.633263
P407
P577
2006-10-23T00:00:00Z